There are TauRx with their tau aggregation inhibitor (formulated of methylene blue) and Noscira with an inhibitor of tau phosphorylation. Think both in phase II (not following closely), but I don't have high hopes here. Thing about tau is figuring out how to target it and I think it will take few more years before tau based therapies will take off.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.